Poly Medicure Ltd Falls 4.98%: 3 Key Technical and Fundamental Factors Driving the Decline

36 minutes ago
share
Share Via
Poly Medicure Ltd’s shares declined by 4.98% over the week ending 1 October 2026, closing at Rs.1,638.35 compared to Rs.1,724.30 the previous Friday. This underperformance was sharper than the Sensex’s 3.20% fall, reflecting a combination of technical setbacks, a downgrade to Sell by MarketsMojo, and mixed momentum signals that shaped investor sentiment throughout the week.

Key Events This Week

28 Sep: Sharp 5.09% drop amid technical and financial concerns

29 Sep: Downgrade to Sell by MarketsMOJO citing weakening fundamentals

1 Oct: Mild recovery with 2.07% gain but mixed technical signals persist

2 Oct: No trading data available; week closes with overall decline

Week Open
Rs.1,724.30
Week Close
Rs.1,638.35
-4.98%
Week High
Rs.1,674.95
vs Sensex
-1.78%

28 September 2026: Sharp Decline Amid Broader Market Weakness

Poly Medicure’s stock price plunged 5.09% to close at Rs.1,636.50 on 28 September, significantly underperforming the Sensex which fell 1.60% that day. The stock’s intraday volatility was notable, with a high of Rs.1,734.05 and a low of Rs.1,611.80, reflecting investor uncertainty. This sharp drop was the first sign of the week’s negative momentum, coinciding with emerging concerns over the company’s technical and financial health.

29 September 2026: Downgrade to Sell Amplifies Pressure

The following day, Poly Medicure was downgraded from Hold to Sell by MarketsMOJO, citing deteriorating technical indicators and weakening financial fundamentals. Despite a modest 0.27% gain to Rs.1,641.00, the downgrade underscored growing caution. Key financial metrics revealed slowing growth, with operating profit CAGR at 13.82% over five years and a low ROCE of 13.08%. The company’s valuation appeared stretched, trading at a high P/B ratio of 5.4 despite a 10.5% fall in profits over the past year.

Technical indicators shifted from mildly bullish to sideways or bearish, with weekly MACD mildly bearish and monthly MACD outright bearish. The RSI remained neutral, while Bollinger Bands suggested sideways weekly movement but bearish monthly trends. These mixed signals contributed to the downgrade and weighed on investor sentiment.

While markets shift, this one's charging ahead! This Micro Cap from Aquaculture shows the strongest momentum signals in current conditions. Don't miss out on this ride!

  • - Strongest current momentum
  • - Market-cycle outperformer
  • - Aquaculture sector strength

Don't Miss This Ride →

30 September 2026: Technical Setback Amid Continued Market Decline

On 30 September, Poly Medicure rebounded with a 2.07% gain to Rs.1,674.95, the week’s highest close, even as the Sensex declined 0.17%. This intraday recovery suggested some short-term buying interest, supported by daily moving averages maintaining a mildly bullish stance. However, weekly and monthly technical indicators remained cautious, with MACD and KST oscillators signalling bearish momentum and Dow Theory assessments mixed.

Volume increased to 5,228 shares, indicating heightened trading activity. Despite the bounce, the stock remained well below its 52-week high of Rs.2,093.95, reflecting persistent investor wariness amid fundamental concerns.

1 October 2026: Mixed Technical Signals Amid Mild Recovery

Poly Medicure closed at Rs.1,638.35 on 1 October, down 2.19% from the previous day but still reflecting a mild recovery from earlier losses. The stock’s intraday range of Rs.1,685.00 to Rs.1,627.10 showed moderate volatility. Technical momentum shifted subtly from sideways to mildly bullish on daily moving averages, supported by bullish On-Balance Volume (OBV) on weekly and monthly charts, suggesting accumulation by investors.

Nevertheless, key momentum indicators such as weekly MACD and KST remained mildly bearish, while monthly MACD stayed firmly bearish. RSI readings continued to offer no clear directional signal. This complex technical picture indicates a stock at a crossroads, with short-term gains tempered by longer-term caution.

Holding Poly Medicure Ltd from ? See if there's a smarter choice! SwitchER compares it with peers and suggests superior options across market caps and sectors!

  • - Peer comparison ready
  • - Superior options identified
  • - Cross market-cap analysis

Switch to Better Options →

Daily Price Comparison: Poly Medicure Ltd vs Sensex

Date Stock Price Day Change Sensex Day Change
2026-09-28 Rs.1,636.50 -5.09% 34,788.97 -1.60%
2026-09-29 Rs.1,641.00 +0.27% 34,621.52 -0.48%
2026-09-30 Rs.1,674.95 +2.07% 34,564.37 -0.17%
2026-10-01 Rs.1,638.35 -2.19% 34,221.41 -0.99%

Key Takeaways

1. Downgrade to Sell Highlights Fundamental Concerns: The MarketsMOJO downgrade on 29 September reflected deteriorating financial metrics including slowing profit growth, low ROCE, and rising interest expenses. The stock’s valuation remains high relative to earnings power, signalling caution.

2. Technical Indicators Show Mixed to Bearish Momentum: Weekly and monthly MACD and KST oscillators indicate weakening momentum, while RSI remains neutral. Daily moving averages and OBV suggest some short-term accumulation, but longer-term trends remain subdued.

3. Underperformance Relative to Sensex: Poly Medicure’s 4.98% weekly decline outpaced the Sensex’s 3.20% fall, reflecting company-specific challenges amid broader market weakness. Despite a mild recovery on 30 September, the stock closed the week lower, underscoring persistent investor caution.

Conclusion

Poly Medicure Ltd’s week was marked by a significant decline driven by a combination of fundamental and technical headwinds. The downgrade to Sell by MarketsMOJO, citing weakening financial performance and stretched valuation, weighed heavily on sentiment. Technical momentum shifted from mildly bullish to sideways and bearish, with mixed signals complicating the outlook. While short-term volume indicators suggest some accumulation, the stock’s underperformance relative to the Sensex and persistent bearish monthly indicators counsel caution. Investors should closely monitor upcoming technical developments and financial results to assess whether the current consolidation phase will resolve into renewed strength or further weakness.

{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News